The Best Perimenopause Supplements: A Buyer's Guide

The Best Perimenopause Supplements: A Buyer's Guide

The best perimenopause supplement is one that directly targets the systems disrupted by hormonal fluctuations.

Perimenopause is thought of as a time when estrogen runs out. But the data tells a different story. 

When researchers tracked perimenopausal women with daily hormone measurements for six months, average estrogen levels were 88% higher than in younger women [1].

Hidden inside that average was extreme volatility. Within individual women, estrogen levels would swing from nearly undetectable to peaks three times higher than typical premenopausal levels.

Progesterone goes in the opposite direction. As ovulation drops off, luteal-phase progesterone falls 40% lower — leaving more of the cycle exposed to unopposed estrogen.

This is the hormonal environment that perimenopause supplements have to wrestle with. Not a gradual fade, but dramatic oscillations that derail thermoregulation, mood, sleep, stress resilience, and the gut-brain axis.

This guide breaks down what happens during perimenopause, which supplement ingredients have clinical evidence, and how to evaluate supplements for perimenopause based on the research.

Perimenopause Supplements Key Takeaways

  • The best perimenopause supplements address multiple biological systems affected by fluctuating estrogen and declining progesterone. Look for formulas that support thermoregulation, mood and sleep, stress regulation, the gut-brain axis, and healthy estrogen metabolism.*

  • The best supplements for perimenopause use ingredients backed by human clinical trials. Standardized rhapontic rhubarb and black cohosh have clinical evidence for hot flashes; chamomile for sleep; shatavari for stress; L. gasseri CP2305 for menopausal changes; and DIM for healthy estrogen metabolism.*

  • When comparing perimenopause supplements, check the exact extract and dose, not just the ingredient name. Look for standardized ingredients in the forms and amounts supported by research, with individual doses clearly disclosed rather than hidden in proprietary blends.

  • A complete perimenopause supplement combines complementary ingredients rather than relying on a single ingredient or mechanism. Hot flashes, sleep, mood, stress, gut-brain signaling, and estrogen metabolism are interconnected, making multi-pathway support a better match for the biology of perimenopause.*

How Perimenopause Supplements Work: Five Biological Systems

A perimenopause supplement works by intervening in the systems that are disrupted by hormonal fluctuations, rather than chasing a single symptom. As estrogen becomes erratic and progesterone declines, the hormonal signals that regulate the brain, gut, and stress response are all disrupted. An effective formula supports the major biological mechanisms downstream of these hormonal fluctuations.*

Perimenopause is defined by surges and crashes.

One meta-analysis found that average concentrations of estrogen in perimenopausal women were higher than premenopausal counterparts. But that average doesn't reflect a steady elevation. Across the monthly cycle, estrogen variability in perimenopausal subjects was nearly double that of premenopausal women [2]. 

In other words, higher highs and lower lows.

Estrogen receptors are expressed in nearly every major tissue. As estrogen loses equilibrium, all of these receptors are pinged unpredictably, and the effects radiate across the body [3].

At the same time, the influence of progesterone wanes.

Progesterone comes from the corpus luteum, a temporary structure that forms only if you ovulate. In the six years before menopause, ovulation frequency falls from about 60% of cycles to under 10% [4]. 

No ovulation means no corpus luteum, and that means less progesterone and longer stretches of unopposed estrogen.

As progesterone collapses and estrogen gets unstable, the shared hormonal wiring across the brain, gut, and stress axis starts to misfire. Effective support requires intervening across all of these systems, including thermoregulation (hot flashes), mood and sleep, stress regulationthe gut-brain axis, and estrogen metabolism.*

How Hormonal Fluctuations Trigger Hot Flashes

A hot flash feels like a temperature problem, but it isn’t. During a hot flash, core body temperature barely changes. What changes is your brain’s tolerance for that temperature.

Your body doesn’t defend a single temperature. It defends a range. Cooling responses (sweating) turn on above an upper limit, and warming responses (shivering) below a lower threshold. The gap between them is the thermoneutral zone.

In women with hot flashes, that zone is virtually nonexistent, so tiny shifts trigger full‑blown cooling responses [5].

The thermoneutral zone is set in the hypothalamus, the seat of the brain’s thermostat. Its width depends on three things working together:

  • The hormonal signal from estrogen binding receptors on hypothalamic thermoregulatory neurons

  • The neural integration of that signal by surrounding thermoregulatory neurons

  • The autonomic output that executes the response, resulting in sweating and vasodilation [6]

The best perimenopause supplements will hit all three of these failure points.*

How Progesterone Shapes Mood and Sleep

Mood volatility and sleep disruption accompany one another because they share the same underlying neurotransmitter machinery.

Both depend on the brain's capacity for inhibitory signaling: the neural braking system that dampens anxiety as well as initiates and sustains sleep. That signaling is tightly linked to the hormone progesterone.

Progesterone is the precursor to allopregnanolone, one of the most potent calming molecules produced by the brain.

Allopregnanolone acts on GABA-A receptors. When it binds, it turns up the sensitivity of these receptors to GABA, the brain's primary inhibitory neurotransmitter [7].

As progesterone falls, so too does its metabolite, and in turn GABAergic inhibitory tone drops. That translates to worse sleep as well as poorer stress resistance [8].

Natural supplements for perimenopause that activate these GABA‑A receptors give you a way to support the same calming circuitry progesterone used to drive.*

How Perimenopause Rewires the Stress Response

The body’s stress response runs through the hypothalamic‑pituitary‑adrenal (HPA) axis. In a healthy system, cortisol rises rapidly with a stressor, peaks, and then returns back to baseline within about 45–60 minutes.

The menopausal transition fundamentally alters how this system works.

In a standardized lab stress test, premenopausal women started out around 3 ng/mL of salivary cortisol, peaked near 6 ng/mL, and were back at baseline by 45 minutes [9].

Meanwhile, before taking the test, postmenopausal women started at 7 ng/mL of cortisol. 

Then it just kept climbing.

By 45 minutes, when the other women had already returned to baseline, their cortisol was still rising — more than three times the level of the controls at the same timepoint.

That is what a dysregulated stress response looks like: elevated at rest, exaggerated under load, and way too slow to shut off.

Estrogen acts as a governor on the HPA axis, tempering the cortisol cascade and facilitating the shutdown signal. Unstable estrogen attenuates that control, meaning the axis takes longer to reset — or fails to reset altogether [10].

In perimenopause, the goal isn’t to mute stress. It’s to re‑train the stress system so it can respond, and then stand down.*

Perimenopause and the Gut-Brain Axis

The gut-brain axis is the bidirectional network between the digestive system and the central nervous system. Signals travel between the two along chemical and neural channels, primarily via the vagus nerve.

Around 80% of vagus nerve fibers are afferent — carrying information from the gut up to the brain — while only 20% run downward [11]. So, along this pathway, the gut does most of the talking, while the brain listens.

That stream of input helps set autonomic tone. The vagus nerve is the main highway of the parasympathetic nervous system — the “rest‑and‑digest” mode that opposes sympathetic “fight‑or‑flight.”

In perimenopause, that balance just takes hit after hit.

Estrogen normally keeps sympathetic outflow in check. As estrogen grows volatile, that brake is lost. At the same time, declining progesterone erodes GABAergic inhibition [12]. Consequently, the system drifts toward a relentless wired‑but‑tired state.

Emerging supplements for perimenopause that modulate gut–to‑brain signaling can work on the same vagal pathways that these hormones once kept in balance.*

How Estrogen Metabolism Shapes Hormonal Signaling

As ovarian reserve dwindles, the brain compensates by pushing the ovaries harder. In perimenopause, peak levels of estrogen can soar several-fold beyond those seen in normal cycles [1].

The impact of these surges — breast soreness, brain fog, headaches — hinges on how rapidly the body can deactivate the hormonal signal.

The liver has two disposal routes for estrogen:

  • The 2-hydroxy pathway produces metabolites with weak estrogenic activity that are rapidly deactivated and eliminated. So the signal is switched off.

  • The 16α-hydroxy pathway produces metabolites that keep binding and activating estrogen receptors. So the signal basically stays on.

When metabolism is shunted toward the 16α-hydroxy pathway, each estrogen surge creates an endocrine echo, hitting receptors even after the initial hormone has been cleared [13].

Natural supplements for perimenopause can’t prevent those hormonal peaks. But they can help bias estrogen metabolism toward the 2‑hydroxy pathway, so spikes are less likely to reverberate through your system.*

Which Perimenopause Supplement Ingredients Have Clinical Evidence?

Perimenopause supplement ingredients backed by clinical evidence include rhapontic rhubarb, black cohosh, γ-oryzanol, chamomile, shatavari, L. gasseri CP2305, and diindolylmethane (DIM). Together, they act across five biological systems affected during perimenopause: thermoregulation, mood and sleep, stress regulation, the gut-brain axis, and estrogen metabolism.*

Thermoregulation

To tackle hot flashes effectively, perimenopause supplements have to hit all three links in the chain:

  • the hypothalamic estrogen receptors that keep the thermostat from overreacting

  • the neurotransmitter systems that decide how wide your thermoneutral zone is

  • and the autonomic nerves that drive sweating and vasodilation

Each of these perimenopause supplement ingredients have been shown in clinical trials to target these links.*

Menofelis® (Rheum rhaponticum, or rhapontic rhubarb)

Rhapontic rhubarb has been shown to improve hot flashes by targeting hypothalamic estrogen signaling.*

The root contains a class of polyphenols called hydroxystilbene glycosides — structurally related to resveratrol — that selectively activate estrogen receptor‑β, the subtype concentrated in thermoregulatory neurons.

Across clinical trials, a standardized extract has been shown to reduce hot flash frequency and severity, improve sleep, and lower anxiety and physical exhaustion scores [14–18].*

In one 12‑week study of perimenopausal women, total Menopause Rating Scale scores fell by 67% [19].

Black cohosh (Actaea racemosa)

Black cohosh for hot flashes targets the neurotransmitter signaling that sets thermal tolerance.

Unlike rhapontic rhubarb, black cohosh does not activate estrogen receptors.

Instead, its bioactive compounds act on serotonergicdopaminergic, and GABAergic pathways — the neural circuits that decide how wide your thermoneutral zone is and how aggressively the thermostat reacts [21–23].*

A meta-analysis of six trials using standardized extracts (n>1,500) found a moderate-to-large reduction in overall menopausal burden [24].

But it really earns its keep versus hot flashes. In a randomized placebo-controlled trial of 304 women, black cohosh improved overall menopausal burden — with the effect on hot flashes ~70% greater than its effect on other symptoms [25].*

γ-Oryzanol (rice bran extract)

γ-Oryzanol is one of the earliest perimenopause supplements shown to improve hot flashes. It does so via the final link: the autonomic nervous system that executes the heat-loss response.*

γ‑Oryzanol is a mixture of plant lipid compounds called steryl ferulates — ferulic acid attached to plant sterols — extracted from rice bran. It has been used in Japan for menopausal symptoms since the 1960s, where it's understood to function by supporting autonomic nervous system balance [26].*

In an open-label study, 90% of participants reported hot flash improvement after supplementation [27].*

Mood and sleep

Chamomile (Matricaria chamomilla)

Chamomile has long been associated with relaxation, and there is a good biochemical reason for this.

Its active constituent, apigenin, binds to the benzodiazepine binding site of the GABA-A receptor — the same allosteric site naturally modulated by allopregnanolone [28].*

Fortunately, apigenin only acts as a partial modulator, without the full agonist profile that produces sedation or cognitive impairment.

In a randomized trial of chamomile extract, participants moved from poor sleep to clinically normal sleep over 28 days. Their Pittsburgh Sleep Quality Index scores dropped from 8.24 to 5.05, crossing the 5-point threshold that separates disturbed from normal sleep [29].*

And emerging data extends these findings to menopause. In a triple‑blind trial, chamomile standardized to 1.2% apigenin improved vasomotor, psychological, physical, and urogenital symptoms in menopausal women [30].*

Stress and the HPA axis

Shatavari (Asparagus racemosus)

Shatavari is an adaptogen: a category of botanicals that help the body maintain equilibrium under strain.*

Shatavari’s benefits for women come from steroidal saponins called shatavarins, which modulate HPA axis activity as well as the neurotransmitter systems (serotonin, dopamine, GABA) that shape how you perceive and recover from stress [31, 32].*

In a randomized, placebo‑controlled trial of 80 perimenopausal women, 8 weeks of standardized shatavari extract pushed perceived stress (PSS‑10) scores down from 24 to 17, moving toward the low‑stress range. Meanwhile, in the placebo group, scores went the opposite direction, from 24 up to 28 — firmly into high‑stress territory [33].*

Gut-brain axis

L. gasseri CP2305

L. gasseri CP2305 works through signaling between the digestive system and the nervous system, which operates independently of hormonal pathways.*

CP2305 is a postbiotic, meaning a heat‑inactivated strain of Lactobacillus gasseri normally found in the human gut. Although the bacteria are no longer alive, their intact cellular components still interact with gut receptors [34]. Through vagus nerve signaling, they tilt autonomic tone toward the parasympathetic "rest-and-digest" state.*

In a double-blind placebo-controlled trial of 80 women, six months of L. gasseri CP2305 significantly improved menopausal changes across vasomotor, psychological, and somatic domains — without influencing hormone levels [35].*

Estrogen metabolism

Diindolylmethane (DIM)

Where most perimenopause supplements act upstream on hormonal signaling, DIM acts downstream, determining what happens to estrogen after a surge [36].*

DIM is a bioactive compound derived from cruciferous vegetables, like broccoli and kale. When these vegetables are chopped or chewed, they release indole-3-carbinol (I3C), which is then converted by stomach acid into DIM.

Inside the liver, DIM pushes estrogen down the 2‑hydroxyestrone pathway, which produces weaker metabolites that are deactivated and cleared more readily [37].*

This has been demonstrated in randomized trials and observational data alike [38].

In a real-world analysis of women taking DIM, the 2:16 ratio climbed from 5.7 to 18.2 — a 188% increase in the pathway associated with faster clearance [39].*

How Should You Evaluate a Perimenopause Supplement?

When evaluating perimenopause supplements, look beyond marketing hype. The best perimenopause supplements use ingredients supported by human clinical trialsprovide them in the same standardized forms and doses used in research, and combine complementary ingredients that support multiple systems affected by perimenopause.*

Is the mechanism supported by trials?

A plausible mechanism is a great starting point. Whether it survives human testing is what really matters.

Wild yam is a classic example. It has been marketed for decades as a “natural progesterone” because it contains diosgenin, a plant sterol that chemists can convert into progesterone in the lab.

Unfortunately, that bench science didn’t translate to living tissue.

Conversion of diosgenin to progesterone requires the Marker degradation reaction — a synthetic chemical process that literally cannot occur inside the human body.

When researchers tested a wild yam cream in women with menopausal symptoms, three months of use produced no changes in progesterone, estrogen, or hot flashes beyond placebo [41].

Animal data, cell cultures, and biological plausibility are not enough. Look for ingredients that have helped women in controlled trials. Treat everything else as speculative.

Is the extract standardized to a clinically studied form?

Plants are chemically variable by nature, and often tremendously. A shatavari root harvested in one region might contain several times the shatavarins of a root grown elsewhere.

Standardization is how manufacturers control that variability. A standardized extract is processed and tested to deliver a specified percentage of active compounds — the molecules responsible for the botanical’s biological effects.

When a study shows that a plant extract works, it shows that a particular preparation with a defined chemical profile produced the effect. A different preparation of the same plant, with different levels of active compounds, cannot be assumed to produce the same results.

Does the dose match what was actually tested?

Even the right extract won’t do what the label suggests if there isn’t enough of it in the capsule.

That sounds...obvious.

But you can't check whether the dose matches the trials if the label doesn't tell you the dose.

That's where "proprietary blends" come in.

A proprietary blend is a labeling practice that groups multiple ingredients under a single line item and discloses only the total weight of the blend. Individual doses are hidden. This is permitted under FDA regulations.

Here's what that looks like.

Example Supplement Facts panel illustrating how a proprietary blend appears on a perimenopause supplement label, with only the total blend weight disclosed.

For a perimenopause supplement, this should be a dealbreaker. Choose products that disclose the exact dose of each active ingredient.

Does it target more than one system?

The systems affected by perimenopause don't operate in isolation. They feed each other.

Hot flashes disrupt sleep. Poor sleep heightens stress reactivity. Stress dysregulates gut function. Gut dysregulation affects mood. Because these systems are linked, targeting a single pathway may leave the rest of the network untouched.

Look for perimenopause supplements that encompass the full perimenopause experience with ingredients that act through complementary pathways.

The Best Perimenopause Supplements Meet These Four Standards

The best supplements for perimenopause don’t hang everything on a single ingredient or chase just one symptom. They combine clinically studied ingredients that address the major biological systems disrupted during the menopausal transition.*

A complete perimenopause supplement will use ingredients that are:

  • supported by human clinical trials

  • standardized to the same forms used in those trials

  • dosed to match the research

  • combined to support multiple biological pathways

Qualia Perimenopause was designed around those principles.*

This hormone-free perimenopause supplement combines seven clinically studied ingredients — including botanical extracts, an adaptogen, a postbiotic, and a bioactive from cruciferous vegetables — selected to support thermoregulation, mood and sleep, stress regulation, the gut-brain axis, and healthy estrogen metabolism.*

Perimenopause Supplement Ingredients: Inside Qualia Perimenopause

Ingredient

Dose

Standardization

Target System

Mechanism

Menofelis® Rheum rhaponticum root extract

4 mg

≥81% hydroxystilbene glycosides

Hot flashes (thermoregulation)

Selective activation of estrogen receptor beta (ERβ) in hypothalamic thermoregulatory neurons

Black cohosh (Actaea racemosa) root extract

40 mg

Hydroethanolic extract, 5% triterpene glycosides

Hot flashes (thermoregulation)

Non-estrogenic action on serotonergic, dopaminergic, and GABAergic pathways that set thermal tolerance

γ-Oryzanol (rice bran extract)

130 mg

Hot flashes (thermoregulation)

Supports autonomic nervous system balance that executes heat-loss responses

Chamomile (Matricaria chamomilla) flower extract

200 mg

1.2% apigenin

Mood & sleep

Apigenin binds the benzodiazepine site of the GABA-A receptor, supporting the inhibitory tone eroded by progesterone decline

Xeya™ Shatavari (Asparagus racemosus) root extract

100 mg

≥15% shatavarins

Stress & the HPA axis

Adaptogenic modulation of HPA axis and neurotransmitter systems (serotonin, dopamine, GABA)

Heat-treated Lactobacillus gasseri CP2305

20 mg

Clinically studied strain

Gut-brain axis

Vagal signaling shifts autonomic tone toward parasympathetic ("rest and digest")

3,3'-Diindolylmethane (DIM)

75 mg

Estrogen metabolism

Activates AhR–CYP1A pathway, biasing estrogen metabolism toward the 2-hydroxyestrone route

Perimenopause Symptoms, 62% Lighter by Day 28*

A perimenopause supplement can look impressive on paper. The real test is how it performs in women.

In a 28-day in-home user study of Qualia Perimenopause, overall perimenopause burden fell by ~62% after 28 days, compared to baseline.*† 

Frequently Asked Questions

What’s the Difference Between Perimenopause and Menopause Supplements?

Perimenopause supplements are designed to address changes caused by fluctuating hormones, while menopause supplements are designed for the consistently low estrogen levels that occur after menopause.*

Perimenopause supplements are for women who are still having menstrual cycles, even if they're irregular. During this stage, estrogen can fluctuate wildly. So perimenopause formulas lean on ingredients that support hot flashes, mood swings, sleep disturbances, and other issues linked to hormone fluctuations.*

Menopause supplements are intended for women who have gone twelve consecutive months without a period. By then, estrogen has stabilized into a persistently low state. These formulas typically place greater emphasis on long-term bone, cardiovascular, and metabolic health, while continuing to manage ongoing changes such as hot flashes and vaginal dryness.*

At What Age Should You Start Taking Perimenopause Supplements?

Symptoms are a better guide than age for determining when to start a perimenopause supplement.*

Perimenopause can begin anywhere from the mid-30s to the mid-50s, though it most commonly starts between 45 and 55 [42].

According to the STRAW+10 staging system — the clinical framework for staging reproductive aging — persistent variability in cycle length of seven days or more marks the beginning of early perimenopause [43].

If you're noticing recurring changes in your menstrual cycle —especially if your cycle has shifted by a week or more — or you're beginning to experience hot flashes or sleep disruptions, those cues are generally more useful than your age alone.*

How Long Do Perimenopause Supplements Take to Work?

Most perimenopause supplements take about 8 to 12 weeks to reach their full effect, so it's best to use them consistently before deciding whether they're working for you. Most clinical trials of ingredients found in perimenopause supplements evaluate results over two to three months.*

Because perimenopausal changes naturally fluctuate from week to week, it’s tough to judge whether a supplement is actually working after only a few days. Using a perimenopause supplement for at least two to three months will enable you to gauge whether it’s making a meaningful difference for you.*


*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.


† Although these results are highly encouraging, the study was not placebo-controlled and contained a small number of participants. Larger, controlled studies will be required to confirm the findings. Individual results may vary.


References

[1] N. Santoro, J.R. Brown, T. Adel, J.H. Skurnick, J. Clin. Endocrinol. Metab. 81 (1996) 1495–1501.

[2] J.C. Prior, Endocr. Rev. 19 (1998) 397–428.

[3] I. Paterni, C. Granchi, J.A. Katzenellenbogen, F. Minutolo, Steroids 90 (2014) 13–29.

[4] H.G. Burger, E.C. Dudley, D.M. Robertson, L. Dennerstein, Recent Prog. Horm. Res. 57 (2002) 257–275.

[5] R.R. Freedman, J. Steroid Biochem. Mol. Biol. 142 (2014) 115–120.

[6] R.R. Freedman, W. Krell, Am. J. Obstet. Gynecol. 181 (1999) 66–70.

[7] D. Belelli, J.J. Lambert, Nat. Rev. Neurosci. 6 (2005) 565–575.

[8] R. Slopien, N. Pluchino, A. Warenik-Szymankiewicz, S. Sajdak, M. Luisi, P. Drakopoulos, A.R. Genazzani, Gynecol. Endocrinol. 34 (2018) 144–147.

[9] F.R. Patacchioli, S. Simeoni, P. Monnazzi, M. Pace, O. Capri, G. Perrone, Maturitas 55 (2006) 150–155.

[10] R.J. Handa, M.J. Weiser, Front. Neuroendocrinol. 35 (2014) 197–220.

[11] B. Bonaz, T. Bazin, S. Pellissier, Front. Neurosci. 12 (2018) 49.

[12] A.V. Ferguson, K.J. Latchford, W.K. Samson, Expert Opin. Ther. Targets 12 (2008) 717–727.

[13] B.T. Zhu, A.H. Conney, Carcinogenesis 19 (1998) 1–27.

[14] J. Wober, F. Möller, T. Richter, C. Unger, C. Weigt, A. Jandausch, O. Zierau, R. Rettenberger, M. Kaszkin-Bettag, G. Vollmer, J. Steroid Biochem. Mol. Biol. 107 (2007) 191–201.

[15] M. Heger, B.M. Ventskovskiy, I. Borzenko, K.C. Kneis, R. Rettenberger, M. Kaszkin-Bettag, P.W. Heger, Menopause 13 (2006) 744–759.

[16] M. Kaszkin-Bettag, B.M. Ventskovskiy, A. Kravchenko, R. Rettenberger, A. Richardson, P.W. Heger, M. Heger, Menopause 14 (2007) 270–283.

[17] M. Kaszkin-Bettag, B.M. Ventskovskiy, S. Solskyy, S. Beck, I. Hasper, A. Kravchenko, R. Rettenberger, A. Richardson, P.W. Heger, Altern. Ther. Health Med. 15 (2009) 24–34.

[18] M. Kaszkin-Bettag, S. Beck, A. Richardson, P.W. Heger, A.-M. Beer, Altern. Ther. Health Med. 14 (2008) 32–38.

[19] J. Shah, S. Chandanani, J. Reddy, H. Kirubamani, A.M. Boruah, A. Jain, S. Mane, P. Biniwale, P. Mathur, A. Ridhorkar, S. Natarajan, B. Tiwari, J. Midlife Health 12 (2021) 108–115.

[20] W. Wuttke, H. Jarry, J. Haunschild, G. Stecher, M. Schuh, D. Seidlova-Wuttke, J. Steroid Biochem. Mol. Biol. 139 (2014) 302–310.

[21] J.E. Burdette, J. Liu, S.-N. Chen, D.S. Fabricant, C.E. Piersen, E.L. Barker, J.M. Pezzuto, A. Mesecar, R.B. Van Breemen, N.R. Farnsworth, J.L. Bolton, J. Agric. Food Chem. 51 (2003) 5661–5670.

[22] S.L. Powell, T. Gödecke, D. Nikolic, S.-N. Chen, S. Ahn, B. Dietz, N.R. Farnsworth, R.B. van Breemen, D.C. Lankin, G.F. Pauli, J.L. Bolton, J. Agric. Food Chem. 56 (2008) 11718–11726.

[23] N.E. Reame, J.L. Lukacs, V. Padmanabhan, A.D. Eyvazzadeh, Y.R. Smith, J.-K. Zubieta, Menopause 15 (2008) 832–840.

[24] C. Castelo-Branco, M. Gambacciani, A. Cano, M.J. Minkin, D. Rachoń, X. Ruan, A.-M. Beer, J. Schnitker, H.-H. Henneicke-von Zepelin, S. Pickartz, Climacteric 24 (2021) 109–119.

[25] R. Osmers, M. Friede, E. Liske, J. Schnitker, J. Freudenstein, H.-H. Henneicke-von Zepelin, Obstet. Gynecol. 105 (2005) 1074–1083.

[26] E. Ramazani, M. Akaberi, S.A. Emami, Z. Tayarani-Najaran, Curr. Pharm. Des. 27 (2021) 2299–2316.

[27] M. Ishihara, Asia Oceania J. Obstet. Gynaecol. 10 (1984) 317–323.

[28] H. Viola, C. Wasowski, M. Levi de Stein, C. Wolfman, R. Silveira, F. Dajas, J.H. Medina, A.C. Paladini, Planta Med. 61 (1995) 213–216.

[29] M. Adib-Hajbaghery, S.N. Mousavi, Complement. Ther. Med. 35 (2017) 109–114.

[30] F. Mohsenzadeh-Ledari, M.A. Delavar, A.A. Moghadamnia, J. Integr. Complement. Med. 32 (2026) 744–751.

[31] N. Singh, M. Garg, P. Prajapati, P.K. Singh, R. Chopra, A. Kumari, A. Mittal, Heliyon 9 (2023) e14932.

[32] S. Majumdar, S. Gupta, S.K. Prajapati, S. Krishnamurthy, Neurochem. Int. 145 (2021) 105013.

[33] P. Yadav, S. Yadav, S.S. Vedururu, G. Kiumari, Funct. Foods Health Dis. 15 (2025) 415–443.

[34] K. Nishida, D. Sawada, Y. Kuwano, H. Tanaka, T. Sugawara, Y. Aoki, S. Fujiwara, K. Rokutan, J. Funct. Foods 36 (2017) 112–121.

[35] D. Sawada, T. Sugawara, T. Hirota, Y. Nakamura, Nutrients 14 (2022) 1695.

[36] D. Amarakoon, W.J. Lee, G. Tamia, S.H. Lee, Annu. Rev. Food Sci. Technol. 14 (2023) 347–366.

[37] I. Chen, A. McDougal, F. Wang, S. Safe, Carcinogenesis 19 (1998) 1631–1639.

[38] E. Godínez-Martínez, R. Santillán, R. Sámano, G. Chico-Barba, M.C. Tolentino, J. Hernández-Pineda, Nutr. Cancer 75 (2023) 510–519.

[39] M. Newman, J. Smeaton, BMC Complement. Med. Ther. 24 (2024) 405.

[40] D.T. Zava, C.M. Dollbaum, M. Blen, Proc. Soc. Exp. Biol. Med. 217 (1998) 369–378.

[41] P.A. Komesaroff, C.V. Black, V. Cable, K. Sudhir, Climacteric 4 (2001) 144–150.

[42] N. Santoro, C. Roeca, B.A. Peters, G. Neal-Perry, J. Clin. Endocrinol. Metab. 106 (2021) 1–15.

[43] S.D. Harlow, M. Gass, J.E. Hall, R. Lobo, P. Maki, R.W. Rebar, S. Sherman, P.M. Sluss, T.J. de Villiers, J. Clin. Endocrinol. Metab. 97 (2012) 1159–1168.

Your Cart

Loading your cart

Your cart is empty

Continue Shopping
Subtotal
You're saving
Checkout View full cart page
100-Day Money-Back Guarantee
Cancel Anytime
Secure Checkout

Sign In